Effect of Chlorhexidine Versus Alcohol on Infections in Neonates

Status Recruiting

Clinical Trial Summary

Chlorhexidine is a local antiseptic that has an important role in the prevention of catheter-associated bloodstream infections. Its application to a newborn's umbilical cord reduces all-cause neonatal mortality.

Clinical Trial Description

Skin disinfection by an appropriate antiseptic agent is essential to prevent healthcare-associated infection. Common pathogens responsible for sepsis have been detected in skin microbiota of hospitalized neonates. Such skin inhabitants can cause sepsis and also lead to blood culture contamination resulting in unnecessary antibiotic use. Strict asepsis bundles have been shown to reduce catheter-related blood stream infection (CRBSI) and contamination rates. The choice of appropriate skin disinfectant is, however, based on low-quality evidence, even in adults. Chlorhexidine gluconate (CHG) is a broad-spectrum antiseptic which is effective against a host of neonatal pathogens. CHG-based products are used frequently in the healthcare setting for peripheral and central venous catheter (CVC) site skin preparation, daily bathing of intensive care unit patients, full-body newborn skin cleansing, umbilical cord care, and Staphylococcus aureus decolonization. In neonates, CHG used as antiseptic for CVC insertion site preparation and maintenance decreases CVC tip microbial colonization. Trials of full-body skin cleansing and umbilical cord care with CHG in the developing world, which included infants less than 34 weeks gestational age, have demonstrated reduced risk of neonatal mortality. Despite proven efficacy of CHG in neonates, current guidelines acknowledge that no recommendations with regards to CHG antisepsis can be made for infants less than 2 months of age due to incomplete safety data in this population. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06194396
Study type	Interventional
Source	Ain Shams University
Contact	Rania A El Farrash, Professor
Phone	+20122228550
Email	rania.elfarrash@med.asu.edu.eg
Status	Recruiting
Phase	N/A
Start date	May 1, 2023
Completion date	July 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04200807` - Non-invasive Measurement of Neonatal Central and Peripheral Hemodynamics
Recruiting	`NCT05695196` - Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant	Phase 1
Completed	`NCT01729000` - Study to Determine if Gloving in Addition to Hand Hygiene Will Prevent Invasive Infections and Necrotizing Enterocolitis	N/A
Completed	`NCT06413056` - Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection	Phase 4
Completed	`NCT03247920` - Reduction of Intravenous Antibiotics In Neonates	Phase 4
Completed	`NCT02486783` - Infection, Sepsis and Meningitis in Surinamese Neonates	N/A
Active, not recruiting	`NCT05343403` - Parental Participation on the Neonatal Ward - the neoPARTNER Study
Recruiting	`NCT04416373` - COVID-19 and Pregnancy Outcomes
Completed	`NCT01540162` - Experience of Mutaflor Suspension Use in Preterm Infants for Immunity Improvement	N/A
Withdrawn	`NCT03673566` - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO	N/A
Completed	`NCT04883801` - Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19
Terminated	`NCT05379452` - Outcomes of Neonates Born to Mothers With SARS-CoV-2 Infection in Shanghai
Active, not recruiting	`NCT04718220` - Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19	N/A
Not yet recruiting	`NCT06102044` - Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania	Phase 3
Active, not recruiting	`NCT04433364` - COPE - COVID-19 in Pregnancy and Early Childhood
Completed	`NCT03383211` - Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers
Completed	`NCT04893343` - Antibiotic Use in a Neonatal Intensive Care Unit Practicing Integrative Medicine
Withdrawn	`NCT03673579` - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB	N/A
Completed	`NCT04206878` - Evaluating the Feasibility of Point of Care Birth Testing in Eswatini
Recruiting	`NCT05743816` - Neonatal Antimicrobial Resistance and Outcome